Efficacy, Toxicity, and Prognostic Factors of Re-treatment With [177Lu]Lu-DOTA-TATE in Patients With Progressing Neuroendocrine Tumors: The Experience of a Single Center

Purpose: Peptide receptor radionuclide therapy (PRRT) is an effective and safe treatment of unresectable or metastatic, progressive neuroendocrine tumours (NETs). However, if progression occurs after the initial PRRT, treatment options remain limited. Our aim was to evaluate the efficacy and safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Maria Manuel, Canha, Marta, Salazar, Daniela, Neves, João Sergio, Ferreira, Gonçalo, Carvalho, Davide, Duarte, Hugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663964/
https://www.ncbi.nlm.nih.gov/pubmed/38021538
http://dx.doi.org/10.7759/cureus.47506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663964/
https://www.ncbi.nlm.nih.gov/pubmed/38021538
http://dx.doi.org/10.7759/cureus.47506

Ejemplares similares